VectivBio (VECT) Competitors $16.85 0.00 (0.00%) As of 06/10/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock VECT vs. MIRM, KNSA, NAMS, VCEL, BLTE, CGON, HRMY, DNLI, VERA, and IMCRShould you be buying VectivBio stock or one of its competitors? The main competitors of VectivBio include Mirum Pharmaceuticals (MIRM), Kiniksa Pharmaceuticals (KNSA), NewAmsterdam Pharma (NAMS), Vericel (VCEL), Belite Bio (BLTE), CG Oncology (CGON), Harmony Biosciences (HRMY), Denali Therapeutics (DNLI), Vera Therapeutics (VERA), and Immunocore (IMCR). These companies are all part of the "pharmaceutical products" industry. VectivBio vs. Mirum Pharmaceuticals Kiniksa Pharmaceuticals NewAmsterdam Pharma Vericel Belite Bio CG Oncology Harmony Biosciences Denali Therapeutics Vera Therapeutics Immunocore VectivBio (NASDAQ:VECT) and Mirum Pharmaceuticals (NASDAQ:MIRM) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, community ranking, dividends, valuation, institutional ownership and earnings. Which has higher valuation and earnings, VECT or MIRM? VectivBio has higher earnings, but lower revenue than Mirum Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVectivBio$27.34M20.97-$93.74MN/AN/AMirum Pharmaceuticals$379.25M6.28-$163.41M-$1.61-29.88 Is VECT or MIRM more profitable? VectivBio has a net margin of 0.00% compared to Mirum Pharmaceuticals' net margin of -31.69%. VectivBio's return on equity of 0.00% beat Mirum Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets VectivBioN/A N/A N/A Mirum Pharmaceuticals -31.69%-41.22%-14.81% Which has more volatility and risk, VECT or MIRM? VectivBio has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Comparatively, Mirum Pharmaceuticals has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500. Does the MarketBeat Community prefer VECT or MIRM? Mirum Pharmaceuticals received 126 more outperform votes than VectivBio when rated by MarketBeat users. Likewise, 76.40% of users gave Mirum Pharmaceuticals an outperform vote while only 43.48% of users gave VectivBio an outperform vote. CompanyUnderperformOutperformVectivBioOutperform Votes1043.48% Underperform Votes1356.52% Mirum PharmaceuticalsOutperform Votes13676.40% Underperform Votes4223.60% Does the media prefer VECT or MIRM? In the previous week, Mirum Pharmaceuticals had 8 more articles in the media than VectivBio. MarketBeat recorded 8 mentions for Mirum Pharmaceuticals and 0 mentions for VectivBio. Mirum Pharmaceuticals' average media sentiment score of 0.78 beat VectivBio's score of 0.00 indicating that Mirum Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment VectivBio Neutral Mirum Pharmaceuticals Positive Do analysts rate VECT or MIRM? Mirum Pharmaceuticals has a consensus target price of $60.73, indicating a potential upside of 26.23%. Given Mirum Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Mirum Pharmaceuticals is more favorable than VectivBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VectivBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Mirum Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 3.17 SummaryMirum Pharmaceuticals beats VectivBio on 10 of the 15 factors compared between the two stocks. Get VectivBio News Delivered to You Automatically Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VECT vs. The Competition Export to ExcelMetricVectivBioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$573.24M$3.11B$5.58B$8.67BDividend YieldN/A1.59%5.27%4.19%P/E RatioN/A33.8627.2320.12Price / Sales20.97477.03423.64161.29Price / CashN/A168.6838.2534.64Price / BookN/A3.497.114.72Net Income-$93.74M-$72.35M$3.23B$247.80M7 Day PerformanceN/A7.99%3.67%2.77%1 Month PerformanceN/A22.61%13.11%9.75%1 Year PerformanceN/A-16.11%32.12%15.01% VectivBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030High Trading VolumeMIRMMirum Pharmaceuticals2.9102 of 5 stars$45.29-1.5%$60.73+34.1%+91.7%$2.24B$379.25M-22.42140Positive NewsAnalyst RevisionKNSAKiniksa Pharmaceuticals2.9937 of 5 stars$29.11+4.3%$38.80+33.3%+54.9%$2.12B$481.17M-207.91220High Trading VolumeNAMSNewAmsterdam Pharma2.6311 of 5 stars$18.69-1.3%$43.00+130.1%+11.0%$2.10B$47.14M-9.944Trending NewsAnalyst ForecastAnalyst RevisionVCELVericel3.2004 of 5 stars$41.57+2.7%$61.14+47.1%+5.0%$2.09B$238.54M692.95300Positive NewsBLTEBelite Bio2.2191 of 5 stars$64.82-0.3%$96.67+49.1%+24.8%$2.06BN/A-58.4010Analyst RevisionCGONCG Oncology2.2729 of 5 stars$26.79+0.8%$58.22+117.3%-22.0%$2.04B$662,000.00-17.7461Positive NewsAnalyst RevisionHRMYHarmony Biosciences4.9537 of 5 stars$35.31-0.7%$53.00+50.1%+19.8%$2.03B$744.85M16.73200Positive NewsAnalyst RevisionDNLIDenali Therapeutics4.3629 of 5 stars$13.93-0.2%$33.71+142.0%-27.4%$2.02B$330.53M-5.05430Positive NewsAnalyst RevisionVERAVera Therapeutics2.8059 of 5 stars$30.91-2.6%$65.00+110.3%-42.0%$1.97BN/A-11.8440Analyst RevisionHigh Trading VolumeIMCRImmunocore2.8679 of 5 stars$38.640.0%$58.89+52.4%-11.2%$1.94B$333.58M-40.67320Positive NewsAnalyst Revision Related Companies and Tools Related Companies MIRM Alternatives KNSA Alternatives NAMS Alternatives VCEL Alternatives BLTE Alternatives CGON Alternatives HRMY Alternatives DNLI Alternatives VERA Alternatives IMCR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VECT) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VectivBio Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share VectivBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VECT Stock Free VECT Stock Alerts